Ibogaine is a drug that has been mentioned by many former heroin addicts to be the reason why they quit heroin. It is a drug that has been reported to significantly reduce the opioid withdrawal symptoms that occur when a heroin user tries to quit. However, it is illegal in the US and considered a schedule 1 drug and so in this video we will talk about how ...
Dosed is a feature documentary that has the power to help the 300 million people in the world suffering from illnesses like anxiety and depression, as well as the 1.3 billion people struggling with addictions of all kinds. Please get involved on social media @DoseMovie on instagram, facebook, twitter. Let’s get educated on this important cause and please donate to the film so we can make sure ...
Continue Reading →
It has become increasingly difficult to assist an individual to maintain long term recovery from substance abuse. Irrespective of which treatment centre the individual has been to, none guarantees a successful recovery. This is frustrating to individuals, their families and also service providers. The reason for this trend is not absolutely clear. Many treatment centres are rigid in use of their programs and depend on aftercare to ...
The African psychoactive alkaloid Ibogaine, Schedule 1 in the USA, researched for substance use since the 1950’s, has demonstrated effectiveness in reversing tolerance & craving for opioids, stimulants & alcohol. Risks & fatalities are involved, due to the demographic, screening, inducing bradycardia, prolonging the QT interval & blocking the Potassium hERG channel, further complicated by opioid maintenance medications & psychiatric drugs. Almost all ibogaine centres, rapidly increasing ...
Ibogaine shares receptor effects with both Salvia divinorum (κ-opiate down-regulation of tolerance via beta-arrestin) and with ketamine (NMDA antagonism, curbing narcotic withdrawal and super-sensitization to stimulants). Additionally, ibogaine induces the nerve growth factor GDNF (Glia-Derived Neurotrophic Factor), re-sprouting chronically desensitised dopamine receptors and replacing the neural deficit experienced as craving. Moreover, the 10-fold GDNF spike engendered by ibogaine back-signals to cell nuclei to make more GDNF, setting ...